H2020-funded Cooperation in Science and Technology ranked Number One
The H2020-funded Cooperation in Science and Technology (COST) led by Professor Lorraine O’Driscoll, has been ranked number one when evaluated by the Commission.
Interest in exosomes and microvesicles (collectively termed extracellular vesicles (EV)) is escalating because of their involvement in many physiological and pathological processes including cancer, immune modulation, Alzheimer’s disease, Parkinson’s disease and their potential to be exploited as naturally-occurring delivery vehicles.
To ensure that research in this field is done according to best practice and to the highest standard possible, thus helping to ensure that the outcome can be translated to societal and economic benefit in a timely manner, Professor Lorraine O’Driscoll established the first international consortium on Microvesicles and Exosomes in Health and Disease.
The Consortium, including researchers from academia, clinics and industry in 28 European countries, the US and Australia, is summarised in this short educational video: